SCHEMBL4456989

SCHEMBL4456989

NC1=NC(N)(c2cccc3ccccc23)NC=C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
KEAP1 Q14145 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SLC6A3 Q01959 7/20 0.36
SLC6A4 P31645 5/20 0.36
SLC6A2 P23975 4/20 0.36
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
F12 P00748 1/20 0.33
PLAU P00749 1/20 0.33
NCF1 P14598 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29101739 0.68 SLC6A3 (0.38) ALDH1A1CYP3A4HPGDTSHRKEAP1
SCHEMBL29876796 0.63 SLC6A3 (0.53) ALDH1A1CYP3A4HPGDTSHRKEAP1
SCHEMBL25155197 0.63 SLC6A3 (0.53) ALDH1A1CYP3A4HPGDTSHRKEAP1
SCHEMBL27961876 0.62 SLC6A3 (0.41) ALDH1A1CYP3A4HPGDTSHRKEAP1
SCHEMBL30344006 0.61 SLC6A3 (0.45) ALDH1A1CYP3A4HPGDTSHRKEAP1
SCHEMBL25155130 0.60 SLC6A3 (0.54) SLC6A3SLC6A4SLC6A2
SCHEMBL30343860 0.60 SLC6A3 (0.54) SLC6A3SLC6A4SLC6A2
SCHEMBL20104711 0.59 SLC6A3 (0.62) SLC6A3SLC6A4SLC6A2
SCHEMBL25155278 0.59 SLC6A3 (0.45) ALDH1A1CYP3A4HPGDTSHRKEAP1
SCHEMBL16579375 0.58 SLC6A3 (0.45) ALDH1A1CYP3A4HPGDTSHRKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO disclosed